Reta glucagon-like peptide-1 (GLP-1) receptor agonists provide a groundbreaking method to diabetes management. These innovative therapies work by mimicking the physiological actions of GLP-1, a hormone produced by the https://socialmphl.com/story22988911/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes